ReviewInternal medicine journal2022

Sodium-glucose co-transporter 2 inhibitor therapy: use in chronic kidney disease and adjunctive sodium restriction.

Mansi Tiwary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.